Document is current
Any future updates will be listed below
-
Authors
Li, Yong https://orcid.org/0000-0003-2011-5916
Dong, Yan
Yang, Luodan
Tucker, Lorelei
Zong, Xuemei
Brann, Darrell
Hamblin, Michael R. https://orcid.org/0000-0001-6431-4605
Vazdarjanova, Almira https://orcid.org/0000-0002-3848-8895
Zhang, Quanguang https://orcid.org/0000-0001-6499-7952
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS086929)
American Heart Association (AHA00169)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (NIA00051)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI050875)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI121700)
National Science Foundation (NSF1258111)
- License Information
-
More Information
Article History
Received: 13 July 2020
Revised: 17 March 2021
Accepted: 29 March 2021
First Online: 15 April 2021
Compliance with ethical standards
:
: MRH declares the following potential conflicts of interest. Scientific Advisory Boards; Transdermal Cap Inc, Cleveland, OH; BeWell Global Inc, Wan Chai, Hong Kong; Hologenix Inc. Santa Monica, CA; LumiThera Inc, Poulsbo, WA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA; Global Photon Inc, Bee Cave, TX; Medical Coherence, Boston MA; NeuroThera, Newark DE; JOOVV Inc, Minneapolis-St. Paul MN; AIRx Medical, Pleasanton CA; FIR Industries, Inc. Ramsey, NJ; UVLRx Therapeutics, Oldsmar, FL; Ultralux UV Inc, Lansing MI; Illumiheal & Petthera, Shoreline, WA; MB Lasertherapy, Houston, TX; ARRC LED, San Clemente, CA; Varuna Biomedical Corp. Incline Village, NV; Niraxx Light Therapeutics, Inc, Boston, MA. Consulting; Lexington Int, Boca Raton, FL; USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V. Eindhoven, Netherlands; Johnson & Johnson Inc, Philadelphia, PA; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholdings: Global Photon Inc, Bee Cave, TX; Mitonix, Newark, DE. The other authors report no financial interests or potential conflicts of interest.
